Appetite for Omniome

How next-gen sequencing play Omniome raised its B round led by Chinese investors

An experienced team and a growing DNA sequencing market in China enabled San Diego’s Omniome Inc. to raise a $60 million series B round led by Chinese investors.

Decheng Capital and Hillhouse Capital Group co-led

Read the full 355 word article

User Sign In